Literature DB >> 5967698

In vivo effects of Agkistrodon rhodostoma venom: studies with fibrinogen-131I.

E Regoeczi, J Gergely, A S McFarlane.   

Abstract

Mesh：

Substances：

Year:  1966        PMID： 5967698      PMCID： PMC292792          DOI： 10.1172/JCI105426

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  23 in total

1.  ORIGIN OF BLOOD FIBRINOLYTIC ACTIVITY.

Authors:  R HOLEMANS
Journal:  Lancet       Date:  1963-08-17       Impact factor: 79.321

2.  THE INFLUENCE OF VENOUS OCCLUSION ON THE FIBRINOLYTIC ACTIVITY OF BLOOD.

Authors:  M ATA; P S AZEEM; J R TIGHE
Journal:  Clin Sci       Date:  1964-12       Impact factor: 6.124

3.  A STUDY OF THE COAGULANT ACTION OF EIGHT SNAKE VENOMS.

Authors:  L NAHAS; R G MACFARLANE; K W DENSON
Journal:  Thromb Diath Haemorrh       Date:  1964-12-31

4.  Studies on the character and staining of fibrin.

Authors:  A C LENDRUM; D S FRASER; W SLIDDERS; R HENDERSON
Journal:  J Clin Pathol       Date:  1962-09       Impact factor: 3.411

5.  Prolonged coagulation defect (defibrination syndrome) in Malayan viper bite.

Authors:  H A REID; K E CHAN; P C THEAN
Journal:  Lancet       Date:  1963-03-23       Impact factor: 79.321

6.  Catabolism of plasma albumin by the perfused rat liver.

Authors:  S COHEN; A H GORDON
Journal:  Biochem J       Date:  1958-12       Impact factor: 3.857

7.  The fibrinolytic system in human blood, as exemplified in a case of agammaglobulinemia and a case of macroglobulinemia.

Authors:  T ASTRUP; J PIPER; J RASMUSSEN
Journal:  Scand J Clin Lab Invest       Date:  1960       Impact factor: 1.713

8.  [Electrophoresis of Ancistrodon rhodostoma boie venom].

Authors:  H PLAGNOL; P MARTIN
Journal:  Ann Inst Pasteur (Paris)       Date:  1957-04

9.  The preparation of human fibrinogen free of plasminogen.

Authors:  M W MOSESSON
Journal:  Biochim Biophys Acta       Date:  1962-02-26

Review 10.  Fibrinogen and fibrin, their roles in health and disease. Normal metabolism.

Authors:  E Adelson
Journal:  Fed Proc       Date:  1965 Jul-Aug
View more
  14 in total

1.  In vivo defibrination results in markedly decreased amounts of fibrinogen in rat megakaryocytes and platelets.

Authors:  P J Handagama; M A Shuman; D F Bainton
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

2.  Protection of pregnant mice with phospholipase C and with Arvin against foetal death induced by bacterial lipopolysaccharide.

Authors:  A Kaplun; J Ferluga; H Prydz; A C Allison
Journal:  Br J Exp Pathol       Date:  1979-04

3.  Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.

Authors:  S V Pizzo; M L Schwartz; R L Hill; P A McKee
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

Review 4.  Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.

Authors:  D Ogston; A S Douglas
Journal:  Drugs       Date:  1971       Impact factor: 9.546

5.  Postsurgical hemorrhage in dogs anticoagulated with ancrod (Arvin).

Authors:  C L Slade; L M Taylor; A S Wechsler; P A McKee
Journal:  Ann Surg       Date:  1973-12       Impact factor: 12.969

6.  Coagulation and fibrinolysis after injury.

Authors:  P T Flute
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1970

7.  A new anticoagulant.

Authors: 
Journal:  Br Med J       Date:  1968-09-28

8.  The effect of Arvin on experimental immune arthritis in rabbits.

Authors:  P M Ford; W R Bell; R Bluestone; J M Gumpel; F W Webb
Journal:  Br J Exp Pathol       Date:  1970-02

9.  Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit.

Authors:  S R Holdsworth; P G Tipping
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

10.  Labelled polyvinylpyrrolidone as an in vivo indicator of reticuloendothelial activity.

Authors:  E Regoeczi
Journal:  Br J Exp Pathol       Date:  1976-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.